Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which ...

CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...

Researchers have developed new CAR-T cells to target malignant tumors. Their method targeted a protein found in high amounts ...

B lymphocytes exhibit dual roles in tumorigenesis, acting as both allies and adversaries in the tumor microenvironment (TME).

T cells are a promising cancer therapy that are made from the patient's own T cells, which are reprogrammed to fight their ...

A study in Chemistry A European Journal reveals that reduced MUC1 antigen density on gold nanoparticles still elicits potent ...

Our immune system is designed to protect us by recognizing and attacking infected or abnormal cells. However, cancer cells ...

† Department of Biological Sciences, School of Life Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 689-798, Korea ‡ Soonchunhyang Institute of Medi-bio Science (SIMS), ...

A clinical trial using engineered immune cells to hunt cancer cells has reported impressive results for solid tumours, a type ...

At the heart of innovation is T-win®, a groundbreaking vaccine platform that could change how we treat cancer.